Cargando…

Towards understanding androgen receptor-independent prostate cancer: an evolving paradigm

Detalles Bibliográficos
Autores principales:	Zhou, Jianfu, Wang, Yuliang, Xiang, Songtao, Chan, Franky L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798568/ https://www.ncbi.nlm.nih.gov/pubmed/35117385 http://dx.doi.org/10.21037/tcr.2020.01.25

Ejemplares similares

Orphan nuclear receptors as regulators of intratumoral androgen biosynthesis in castration-resistant prostate cancer
por: Zhou, Jianfu, et al.
Publicado: (2021)

Nuclear receptor ERRα contributes to castration-resistant growth of prostate cancer via its regulation of intratumoral androgen biosynthesis
por: Xu, Zhenyu, et al.
Publicado: (2020)

Liver transplantation for non-resectable colorectal metastases—an evolving paradigm in transplant oncology
por: Hobeika, Christian, et al.
Publicado: (2023)

Understanding Quality Paradigm Shifts in the Evolving Pharmaceutical Landscape: Perspectives from the USP Quality Advisory Group
por: Weitzel, Jane, et al.
Publicado: (2021)

Chromogranin A is a predictor of prognosis in patients with prostate cancer: a systematic review and meta-analysis
por: Guo, Zhenlang, et al.
Publicado: (2019)

Protein translation controlled by the androgen receptor in prostate cancer: a novel therapeutic option?
por: Mirzakhani, Kimia, et al.
Publicado: (2020)

Evolving perspectives of the role of novel agents in androgen-independent prostate cancer
por: Kalmadi, Sujith, et al.
Publicado: (2008)

Evolving treatment paradigms in recurrent and metastatic head and neck squamous cell carcinoma: the emergence of immunotherapy
por: Faraji, Farhoud, et al.
Publicado: (2023)

Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription
por: Jia, Lin, et al.
Publicado: (2018)

Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy?
por: Peinetti, Nahuel, et al.
Publicado: (2022)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

Evolving paradigms in cardiogenic shock care
por: Tehrani, Behnam N., et al.
Publicado: (2019)

Androgen receptor splice variant 7 in castration resistant prostate cancer treated with hormonal therapy: what is in the pipeline?
por: Chirra, Martina, et al.
Publicado: (2019)

Novel lipid mediators contributing to androgen receptor therapy resistance in prostate cancer
por: Chinni, Sreenivasa R.
Publicado: (2021)

Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes
por: Hussein, Mohamed Ali, et al.
Publicado: (2023)

Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer
por: Wen, Simeng, et al.
Publicado: (2020)

Effects of androgen deprivation therapy duration and Gleason grade on survival outcomes of high risk prostate cancer
por: Kim, Do Kyung, et al.
Publicado: (2019)

Role of androgen receptor splice variants in prostate cancer metastasis
por: Xu, Jin, et al.
Publicado: (2016)

‘Cells as tools’ to ‘Cell-s produced tools’ - An evolving paradigm in Regenerative Medicine
Publicado: (2017)

Toward a patient-based paradigm for blood transfusion
por: Farrugia, Albert, et al.
Publicado: (2014)

Biomarkers of Response to Neoadjuvant Androgen Deprivation in Localised Prostate Cancer
por: Pechlivanis, Maree, et al.
Publicado: (2021)

A phosphorylation switch controls androgen biosynthesis in prostate cancer
por: Qiu, Yun
Publicado: (2023)

Understanding the Complex Relationship Between Androgens and SARS-CoV2
por: Ory, Jesse, et al.
Publicado: (2020)

Androgen resistance in prostate cancer
por: Waxman, J, et al.
Publicado: (2008)

From the Tip to the Iceberg Below—Evolving Our Molecular Understanding of Thyroid Nodules
por: Alexander, Erik K
Publicado: (2021)

Commentary: Evolving understanding of coronavirus disease 2019: Molecular biology, immunology, and surgery
por: Buratto, Edward, et al.
Publicado: (2021)

Aortic Counterpulsation for Myocardial Support: Towards a New Paradigm
por: Choudhury, Arindam
Publicado: (2019)

Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-κB/p65 and MUC1-C
por: Li, Jing, et al.
Publicado: (2015)

Statins and adrenal androgen levels in prostate cancer: A new twist
por: Mostaghel, Elahe A
Publicado: (2021)

Destroying the androgen receptor (AR)-potential strategy to treat advanced prostate cancer
por: Narayanan, Ramesh, et al.
Publicado: (2017)

Mechanisms of Androgen-Independent Prostate Cancer
por: Saraon, Punit, et al.
Publicado: (2014)

Targeting androgen receptor-independent pathways in therapy-resistant prostate cancer
por: Xu, Lingfan, et al.
Publicado: (2019)

SHH-N non-canonically sustains androgen receptor activity in androgen-independent prostate cancer cells
por: Trnski, Diana, et al.
Publicado: (2021)

Lung stem cells - from an evolving understanding to a paradigm shift?
por: Hayes, Mairéad, et al.
Publicado: (2011)

Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens
por: Dart, D. A., et al.
Publicado: (2011)

Abiraterone acetate, an inhibitor of adrenal androgen synthesis in “hormone refractory prostate cancer”
por: Goel, Arun Kumar, et al.
Publicado: (2011)

Introduction to the Special Issue on “Keratinocyte Carcinomas: Biology and Evolving Non-Invasive Management Paradigms”
por: González, Salvador, et al.
Publicado: (2023)

Staghorn calculi: Understanding the paradigm shift in management
por: Desai, Mahesh, et al.
Publicado: (2020)

Advances in glaucoma surgery: Paradigm shift in management
por: Pathak-Ray, Vanita
Publicado: (2016)

Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells.
por: Sherwood, E. R., et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_ipss4rvtlae91ju48fijrfcgt1